Shares of Max Healthcare Institute Limited experienced a decline of 2.32% to trade at Rs 1,193.10 in Tuesday's session. The stock witnessed high volume and a surge in trading activity during the session. Max Healthcare Institute Limited is included as one of the stocks in the NIFTY MIDCAP 150 index.
Financial Overview:
Max Healthcare Institute Limited's financial performance shows consistent growth in both quarterly and annual results. Here's a detailed look:
Consolidated Quarterly Results:
The quarterly performance of Max Healthcare reveals a steady increase in revenue and net profit over the recent periods.
| Heading | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Revenue | Rs 1,542.95 Crore | Rs 1,707.46 Crore | Rs 1,868.31 Crore | Rs 1,909.74 Crore | Rs 2,027.57 Crore |
| Net Profit | Rs 236.27 Crore | Rs 281.81 Crore | Rs 238.80 Crore | Rs 319.00 Crore | Rs 307.97 Crore |
| EPS | 2.43 | 2.90 | 2.46 | 3.28 | 3.17 |
Consolidated Yearly Results:
The annual financial data indicates a strong upward trend in revenue and profitability.
| Heading | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | Rs 2,504.67 Crore | Rs 3,931.46 Crore | Rs 4,562.60 Crore | Rs 5,406.02 Crore | Rs 7,028.46 Crore |
| Net Profit | -Rs 114.50 Crore | Rs 605.05 Crore | Rs 1,103.51 Crore | Rs 1,057.64 Crore | Rs 1,075.88 Crore |
| EPS | -1.59 | 6.25 | 11.38 | 10.89 | 11.07 |
| BVPS | 58.37 | 64.79 | 76.31 | 86.51 | 96.50 |
| ROE | -2.43 | 9.63 | 14.89 | 12.57 | 11.46 |
| Debt to Equity | 0.16 | 0.12 | 0.08 | 0.14 | 0.27 |
Cash Flow:
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Operating Activities | Rs 1,459 Crore | Rs 1,121 Crore | Rs 1,209 Crore | Rs 748 Crore | Rs 117 Crore |
| Investing Activities | -Rs 1,631 Crore | -Rs 1,285 Crore | -Rs 1,187 Crore | -Rs 771 Crore | -Rs 73 Crore |
| Financing Activities | -Rs 163 Crore | -Rs 263 Crore | -Rs 288 Crore | -Rs 294 Crore | Rs 191 Crore |
| Others | Rs 17 Crore | Rs 32 Crore | Rs 0 Crore | Rs 0 Crore | Rs 279 Crore |
| Net Cash Flow | -Rs 318 Crore | -Rs 394 Crore | -Rs 266 Crore | -Rs 317 Crore | Rs 515 Crore |
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Share Capital | Rs 972 Crore | Rs 971 Crore | Rs 970 Crore | Rs 969 Crore | Rs 965 Crore |
| Reserves & Surplus | Rs 8,408 Crore | Rs 7,368 Crore | Rs 6,397 Crore | Rs 5,290 Crore | Rs 4,646 Crore |
| Current Liabilities | Rs 1,813 Crore | Rs 1,248 Crore | Rs 1,045 Crore | Rs 757 Crore | Rs 776 Crore |
| Other Liabilities | Rs 4,019 Crore | Rs 2,410 Crore | Rs 1,688 Crore | Rs 2,171 Crore | Rs 2,155 Crore |
| Total Liabilities | Rs 15,214 Crore | Rs 11,999 Crore | Rs 10,101 Crore | Rs 9,189 Crore | Rs 8,544 Crore |
| Fixed Assets | Rs 8,922 Crore | Rs 6,384 Crore | Rs 4,836 Crore | Rs 4,714 Crore | Rs 4,108 Crore |
| Current Assets | Rs 1,592 Crore | Rs 1,706 Crore | Rs 1,943 Crore | Rs 1,000 Crore | Rs 1,124 Crore |
| Other Assets | Rs 4,699 Crore | Rs 3,909 Crore | Rs 3,322 Crore | Rs 3,474 Crore | Rs 3,311 Crore |
| Total Assets | Rs 15,214 Crore | Rs 11,999 Crore | Rs 10,101 Crore | Rs 9,189 Crore | Rs 8,544 Crore |
| Contingent Liabilities | Rs 1,374 Crore | Rs 1,169 Crore | Rs 326 Crore | Rs 515 Crore | Rs 388 Crore |
| Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | |
|---|---|---|---|---|---|
| Basic EPS (Rs.) | 11.07 | 10.89 | 11.38 | 6.25 | -1.59 |
| Diluted Eps (Rs.) | 11.01 | 10.84 | 11.36 | 6.24 | -1.59 |
| Book Value /Share (Rs.) | 96.50 | 86.51 | 76.31 | 64.79 | 58.37 |
| Dividend/Share (Rs.) | 1.50 | 1.50 | 0.00 | 0.00 | 0.00 |
| Face Value | 10 | 10 | 10 | 10 | 10 |
| Gross Profit Margin (%) | 28.51 | 30.89 | 30.24 | 27.21 | 20.70 |
| Operating Margin (%) | 23.40 | 26.36 | 25.15 | 21.58 | 13.75 |
| Net Profit Margin (%) | 15.30 | 19.56 | 24.18 | 15.38 | -4.57 |
| Return on Networth / Equity (%) | 11.46 | 12.57 | 14.89 | 9.63 | -2.43 |
| ROCE (%) | 12.27 | 13.25 | 12.67 | 10.06 | 4.43 |
| Return On Assets (%) | 7.07 | 8.81 | 10.92 | 6.58 | -1.60 |
| Current Ratio (X) | 0.88 | 1.37 | 1.86 | 1.32 | 1.45 |
| Quick Ratio (X) | 0.82 | 1.30 | 1.79 | 1.24 | 1.38 |
| Debt to Equity (x) | 0.27 | 0.14 | 0.08 | 0.12 | 0.16 |
| Interest Coverage Ratios (X) | 12.15 | 27.89 | 16.45 | 10.61 | 1.92 |
| Asset Turnover Ratio (%) | 0.52 | 0.49 | 0.22 | 0.22 | 29.31 |
| Inventory Turnover Ratio (X) | 74.28 | 0.00 | 0.00 | 0.00 | 46.56 |
| 3 Yr CAGR Sales (%) | 33.71 | 46.91 | 107.56 | 6,170.14 | 4,904.67 |
| 3 Yr CAGR Net Profit (%) | 33.35 | 203.92 | 824.54 | 2,359.78 | 970.05 |
| P/E (x) | 99.09 | 75.29 | 38.76 | 55.62 | -129.40 |
| P/B (x) | 11.37 | 9.48 | 5.78 | 5.35 | 3.53 |
| EV/EBITDA (x) | 54.09 | 47.77 | 30.38 | 31.65 | 38.85 |
| P/S (x) | 15.17 | 14.75 | 9.38 | 8.56 | 7.95 |
Max Healthcare Institute Limited has been actively involved in several corporate actions. Recent announcements include:
With the stock's last traded price at Rs 1,193.10, Max Healthcare Institute Limited saw high volume and a surge in trading activity during the session.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
